Solstice Pharma Initiative - Page 2

Learn how to access and confirm pharmacist counseling notes after picking up your prescription to prevent medication errors and ensure safety.

Explore how blockchain technology is eliminating counterfeit medicines and securing the generic drug supply chain through immutable digital pedigrees and DSCSA compliance.

Learn how to monitor and manage corticosteroid-induced hyperglycemia and steroid-induced diabetes, including risk factors, timing of spikes, and care strategies.

Learn safe ways to discuss medications through encrypted channels designed for patient-provider communication. Covers setup steps, message crafting tips, and platform comparisons.

Discover why insurance companies increasingly require approval for generic drugs. Learn how the process impacts your treatment delays, costs, and what recent 2026 reforms mean for patients.

Explore the side effects of tricyclic antidepressants like amitriptyline and nortriptyline. Learn about common risks, management tips, and comparisons to modern treatments.

Explore what bioequivalent medications mean for your health. Learn how generic drugs are tested, the FDA standards involved, and when you should be cautious about switching brands.

Child-resistant containers and medication safety caps are designed to prevent young children from opening medicine bottles. Learn how they work, why they sometimes fail, and what you can do to keep kids safe - even when the cap seems secure.

Learn where to find the FDA's official list of authorized generics, how to use it, and why it's not always reliable for finding low-cost drug alternatives. Understand the difference between authorized and traditional generics.

Spacing probiotics and antibiotics by at least two hours dramatically improves effectiveness and reduces antibiotic-associated diarrhea. Learn which strains work best, how much to take, and how long to keep using them.

Lung cancer screening saves lives - but only if you know you're eligible. Learn who qualifies, how LDCT works, why so few people get screened, and how targeted therapies like osimertinib are changing survival rates for early-stage patients.

Pediatric exclusivity gives drug makers six months of extra market protection by blocking generic approvals - not by extending patents, but by law. It's a powerful tool that benefits children's health and drug companies alike.